202834 ENACCT's pilot education program: A community-centered model for enhancing cancer clinical trials participation among medically underserved populations

Wednesday, November 11, 2009: 10:50 AM

Margo Michaels, MPH , Executive Director, Education Network to Advance Cancer Clinical Trials, Bethesda, MD
Natasha Blakeney, MPH , Program Director, Education Network to Advance Cancer Clinical Trials, Bethesda, MD
Abbey Britton, BS , Education Department, Decatur Memorial Hospital, Decatur, IL
Liz Swords, BS, MA , Research and Grant Coordinator, Decatur Memorial Hospital, Decatur, IL
Naomi Bitow, MPH , Meharry Medical College, Nashville, TN
Brian K. Gibbs, MPA, PhD , Associate Dean for Diversity and Cultural Competency, Johns Hopkins School of Medicine, Baltimore, MD
Samantha Yeun, BA , TPCHD Prevention Specialist, Tacoma Pierce County Health Department, Tacoma, WA
Bruce B. Rytkonen, BA, MBA , Grants and Contracts Specialist, Tacoma Pierce County Health Department, Tacoma, WA
Robert M. Goodman, PhD , Indiana University, School of Health, Physical Education, and Recreation, Bloomington, IN
Amanda Greene, PHD, MPH, FNP, RN , Office of Science Policy & Public Liaison, National Institute of Nursing Research, Bethesda, MD
Lisbeth Jarama, PhD , NOVA Research Company, Bethesda, MD
Nakia C. Brown, PhD , NOVA Research Company, Bethesda, MD
Cancer clinical trials play a significant role in making progress against cancer. Nationally however, fewer than 3% of adult cancer patients participate, with rates even lower among minorities and medically underserved. ENACCT's (Education Network to Advancer Cancer Clinical Trials) Pilot Education Program (PEP) sought to demonstrate the impact and feasibility of a comprehensive, community-driven outreach and education program to: (1) increase awareness about cancer clinical trials (2) enhance their acceptability, and (3) improve access. PEP utilized an action-oriented train-the-trainer curriculum, focusing on disparities, social justice, patient protection and community dialogue. Cancer clinical trial staff workshops addressed optimization of recruitment and retention practices. Community partnerships also worked with local coalitions and health care institutions to address infrastructure and policy barriers. PEP recruited 75 trainers, who reached 882 community members and 374 health care providers. Additionally 61 cancer clinical trial staff were trained. Among those completing follow-up surveys, 66% of community leaders spoke to others about cancer clinical trials; 94% of health care providers reported willingness to discuss clinical trials with patients. Among cancer clinical trial staff, 80% who completed surveys indicated intention to work with community groups on cancer clinical trials education. Seventy-seven unique patient profiles were created with a national cancer clinical trials matching service. Findings from PEP suggest that community-centered efforts show promise in impacting knowledge, research engagement, and leading to systems change that improve access to clinical trials. New approaches on how to engage stakeholders about cancer clinical trials, including minorities and the medically underserved were also identified.

Learning Objectives:
1.Describe the educational model of ENACCT's Pilot Education Program 2. Identify findings from PEP evaluation 3. Discuss future implications for community cancer clinical trials education

Keywords: Cancer, Clinical Trials

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Ms. Michaels is the founder and Executive Director for ENACCT, serving as the lead course author for all ENACCT curricula. A former Education Branch Chief at the National Cancer Institute (NCI), for the last 10 years Ms. Michaels has developed dozens of programs to educate cancer advocates, community leaders, and health care professionals about policy and science issues related to both cancer and cancer clinical trials. She developed NCIís Clinical Trial Ambassador Program, NCIís Clinical Trial Education Series, and the Clinical Research: Affiliates Funding Trials (CRAFT) program at the Susan G. Komen Breast Cancer Foundation in Dallas, TX (now Komen for the Cure). She was the Director of the National Breast Cancer Coalitionís Project LEAD in the late 90ís. She holds an M.P.H. in Health Behavior/Health Education from the University of North Carolina School of Public Health.
Any relevant financial relationships? Yes

Name of Organization Clinical/Research Area Type of relationship
Eli Lily cancer clinical trials education Educational Grant
sanofi aventis cancer clincial trials education Educational Grant
Genentech cancer clinical trials education Educational Grant
GlaxoSmithKline cancer clinical trials education Grant Support
Pfizer, Inc cancer clinical trials education

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.